` AMRX (Amneal Intermediate Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

AMRX
vs
NOVO B

Over the past 12 months, AMRX has significantly outperformed NOVO B, delivering a return of 22% compared to the NOVO B's 56% drop.

Valuation Comparison

A
AMRX Intrinsic Value
17.634 USD
Undervaluation 55%
Intrinsic Value
Price
NOVO B Intrinsic Value
625.37 DKK
Undervaluation 28%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
A
Amneal Intermediate Inc
NASDAQ:AMRX
7.915 USD
Novo Nordisk A/S
CSE:NOVO B
453.05 DKK

Financials Comparison

Growth Over Time
AMRX vs NOVO B

AMRX
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
A
Amneal Intermediate Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
AMRX vs NOVO B

AMRX
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
A
Amneal Intermediate Inc
NASDAQ:AMRX
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

AMRX
36.7%
NOVO B
84.3%

Operating Margin

AMRX
12.9%
NOVO B
44.6%

Net Margin

AMRX
-0.5%
NOVO B
34.5%

FCF Margin

AMRX
7.4%
NOVO B
24.5%

ROE

AMRX
23.3%
NOVO B
88.1%

ROA

AMRX
-0.4%
NOVO B
26.6%

ROIC

AMRX
6.9%
NOVO B
30.4%

ROCE

AMRX
14.8%
NOVO B
70%

Stocks Performance

Stocks Performance
AMRX vs NOVO B

Loading
AMRX
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
AMRX vs NOVO B

Loading
AMRX
NOVO B
Difference
www.alphaspread.com

Performance By Year
AMRX vs NOVO B

Loading
AMRX
NOVO B
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account